Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

Clinical trial NCT05921305 · RECRUITING

Trial details

NCT number: NCT05921305
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Graft Versus Host Disease

Start date: 2023-08-03
Primary completion: 2026-06-30
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.